Neurogen Corporation

(NASDAQ:NRGN)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 21,227 21,227 21,227 56,170
Cash At End Of Period 22,974 28,935 11,744 21,227
Net Change In Cash And Cash Equivalents 1,747 7,708 -9,483 -34,943
Effect Of Exchange Rate Changes
Net Income Or Loss -29,479 -22,952 -16,518 -55,706
Cash From Operating Activities
Depreciation Expenses 795 678 537 2,281
Amortization Expenses 47 26 164
Amortization Of Intangibles Expenses
Deferred Income Taxes
Operating Gains Or Losses 155 41 164 105
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables 166 156 154 21
Increase Or Decrease In Inventories
Increase Or Decrease In Prepaid Expenses
Increase Or Decrease In Other Current Assets
Increase Or Decrease In Payables
Increase Or Decrease In Other Current Liabilities -3,915 -801 -805 -694
Increase Or Decrease In Other Working Capital
Other Non Cash Items 1,543 -629 -280 -14,527
Net Cash From Continuing Operations -6,138 -5,284 233 4,762
Net Cash From Discontinued Operations -36,873 -28,744 -16,489 -63,594
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment 1,507 1,442
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -194 -165 -165 -822
Acquisitions
Purchase Of Long Term Investments
Purchase Of Short Term Investments
Other Investing Changes Net
Cash From Discontinued Investing Activities
Net Cash From Investing Activities 11,352 8,815 7,373 29,793
Cash From Financing Activities
Issuance Of Debt 28,373 28,373 312
Issuance Of Capital Stock -1,105 -736 -367 -1,454
Repayment Of Debt
Repurchase Of Capital Stock
Payment Of Cash Dividends
Net Other Financing Charges
Cash From Discontinued Financing Activities
Net Cash From Financing Activities 27,268 27,637 -367 -1,142